GLP-1 medications act as a GLP-1 hormone (made in your small intestine) to help slow down the movement of food through your stomach while increasing the feeling of fullness so you eat less
The new results highlight Revitas potential as a compelling first-in-class therapy for post-GLP-1 weight maintenance
If retatrutide works as well as early trials suggest, it shouldnt be too long to wait for FDA review and a real prescription version
The fundamentals, she says, are the same for everyone on the medications or not: enough protein, enough fiber, and nutrient-dense foods that are not overly processed
Reviewers independently undertook study selection, data extraction, and Cochrane risk-of-bias assessment, resolving disagreements by consensus
This does not invalidate the research, but it does mean independent replication and broader academic study remain important